EP Multibagger Stock - Jun 2026
gift nifty image banner
Want a perfect stocks portfolio for 2026? Create Now
Latest News

Biocon reports marginal growth of 2% in net profit for Q4

Biocon has reported approx 2% growth in its net profit at Rs.130 crore, for the quarter ended March 31,2018. The company in the same quarter last fiscal, had posted a profit of Rs.127 crore.

Its total revenue for the quarter under review was up 27% to Rs.1,237 crore, while for the corresponding quarter last year it was at Rs.974 crore. Its net profit for the whole year was down 39% to Rs.372 crore for FY18, as against Rs.612 crore for FY17.

Furthermore, as per the company’s filing to BSE, its board has recommended a final dividend of Re.1 per equity share of face value of Rs.5 each.

Read EquityPandit’s Technical Analysis of Nifty Pharma

Click here to check market prediction for next trading session.




📰
News
📈
Prediction
📊
FII / DII
💼
Portfolio 2026